Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12110324 Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 21, 2023
0
Date of Patent
October 8, 2024
0
Patent Application Number
18356891
0
Patent Citations
‌
US Patent 7964713 Nucleic acid molecules encoding thymic stromal lympopoietin receptor proteins and a process for producing the encoded polypeptides thereof
0
‌
US Patent 9562100 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 9803023 Fc variants with altered binding to FcRn
0
‌
US Patent 10000561 Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
0
‌
US Patent 10287348 Antigen binding proteins capable of binding thymic stromal lymphopoietin
0
‌
US Patent 10336818 Fc variants with altered binding to FcRn
0
‌
US Patent 10722655 Autoinjector with shock reducing elements
0
‌
US Patent 10745473 Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
0
‌
US Patent 10828365 Treatment of asthma with anti-TSLP antibody
0
‌
US Patent 10994011 Pharmaceutical composition comprising anti-human TSLP receptor antibody
0
•••
Patent Inventor Names
Zachary Kohl Costello
0
Antonios O. Aliprantis
0
Ryan Terrell Phennicie
0
Lana Dinic
0
Alexis Hiram Ramos
0
Adam Reid Root
0
Kristen Park Hopson
0
Anthony John Coyle
0
Karin Alma Frieda Reif
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12110324
0
Patent Primary Examiner
‌
Michael Szperka
0

Find more entities like US Patent 12110324 Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.